BTK Inhibitors in Chronic Lymphocytic Leukemia

2 Views
administrator
administrator
07/08/23

Brad S. Kahl, MD, explores the most recent data surrounding the use of Bruton tyrosine kinase inhibitors acalabrutinib and zanubrutinib in chronic lymphocytic leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next